Open Government Canada
Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements
Published by Health Canada | Santé Canada
About this dataset
The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21).